ICU Medical, Inc.
ICUI
$133.31
$2.001.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.94% | 0.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.94% | 0.69% | |||
| Cost of Revenue | -4.06% | 0.48% | |||
| Gross Profit | 1.60% | 1.05% | |||
| SG&A Expenses | -0.80% | 1.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.87% | 0.88% | |||
| Operating Income | 16.46% | -2.87% | |||
| Income Before Tax | 75.08% | -353.55% | |||
| Income Tax Expenses | -1,208.48% | -303.19% | |||
| Earnings from Continuing Operations | 291.51% | -363.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 291.51% | -363.31% | |||
| EBIT | 16.46% | -2.87% | |||
| EBITDA | 4.54% | -0.96% | |||
| EPS Basic | 290.93% | -363.15% | |||
| Normalized Basic EPS | 159.40% | -37.30% | |||
| EPS Diluted | 288.29% | -355.21% | |||
| Normalized Diluted EPS | 155.07% | -37.30% | |||
| Average Basic Shares Outstanding | 0.31% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||